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Introduction
The  endosomal  sorting  complexes  required  for  transport   
(ESCRTs) are recruited to the cytosolic surface of endosomes, 
where they selectively package ubiquitinated transmembrane 
protein cargoes into the intralumenal vesicles (ILVs) of multi­
vesicular bodies (MVBs). The ILVs and their cargoes are sub­
sequently degraded upon fusion of MVBs with lysosomes. 
ESCRT­0, ­I, and ­II are stable heteromeric complexes, each 
containing subunits that bind directly to ubiquitin (Ub) linkages 
on the cytosolic domains of cargoes (Piper and Katzmann, 
2007; Raiborg and Stenmark, 2009). Recent studies indicate 
that ESCRT­I and ­II can also induce membrane invaginations 
of nascent ILVs in vitro (Wollert and Hurley, 2010) and that 
ESCRT­II can stimulate assembly of ESCRT­III (Im et al., 2009; 
Saksena et al., 2009).
The polymerization of ESCRT­III subunits is required for 
completion of ILV budding. Genetic and biochemical studies of 
ESCRT­III proteins from Saccharomyces cerevisiae have con­
tributed much to our understanding about assembly of the   
complex, principles that are likely to be generally conserved. 
ESCRT­III in yeast is comprised of four core subunits (Snf7, 
Vps20, Vps24, and Vps2; Babst et al., 2002), the most abundant 
of which is Snf7 (Teis et al., 2008). Polymerization of Snf7 on 
membranes is stimulated upon binding Vps20, which relieves 
an autoinhibitory intramolecular interaction between the N­ and 
C­terminal regions of Snf7 (Teis et al., 2008; Saksena et al., 
2009). Membrane­associated Snf7 polymers are thought to be 
capped by Vps24, which recruits Vps2 (Babst et al., 2002; Teis 
et al., 2008). In turn, Vps2 promotes activation of the AAA­
ATPase Vps4, which catalyzes disassembly of ESCRT­III and 
recycling of its subunits from membranes to the cytosol (Babst 
et al., 1998; Babst et al., 2002). Did2, Ist1, and Vps60 are three 
accessory ESCRT­III subunits that appear to serve primarily as 
regulators of Vps4 activity (Nickerson et al., 2006; Azmi et al., 
2008; Dimaano et al., 2008; Rue et al., 2008).
In vitro reconstitution of ESCRT­III assembly on synthetic 
membranes revealed that excess amounts of the yeast core   
ESCRT­III subunits deform liposomes (Saksena et al., 2009) and 
drive both the formation and detachment of lumenal membrane 
invaginations (Wollert et al., 2009). In limiting amounts, however, 
ESCRT­III subunits lack the ability to deform the membrane 
and, instead, their activity is restricted to facilitating the severing   
of membrane invaginations generated by ESCRT­I and ­II   
(Wollert and Hurley, 2010). These observations suggest that   
ESCRT­III is responsible for execution of the membrane scission 
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ndosomal sorting complexes required for transport 
(ESCRTs) promote the invagination of vesicles into 
the lumen of endosomes, the budding of enveloped 
viruses,  and  the  separation  of  cells  during  cytokinesis. 
These processes share a topologically similar membrane 
scission event facilitated by ESCRT-III assembly at the cyto-
solic surface of the membrane. The Snf7 subunit of ESCRT-III 
in yeast binds directly to an auxiliary protein, Bro1. Like 
ESCRT-III, Bro1 is required for the formation of intralumenal 
vesicles at endosomes, but its role in membrane scission is 
unknown. We show that overexpression of Bro1 or its   
N-terminal Bro1 domain that binds Snf7 enhances the stabil-
ity of ESCRT-III by inhibiting Vps4-mediated disassembly   
in vivo and in vitro. This stabilization effect correlates with 
a reduced frequency in the detachment of intralumenal 
vesicles as observed by electron tomography, implicating 
Bro1 as a regulator of ESCRT-III disassembly and mem-
brane scission activity.
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step during ILV formation. Consistent with these in vitro find­
ings, mammalian ESCRT­III is required during cytokinesis for 
midbody abscission and for the detachment of fully assembled 
retroviruses from the plasma membrane (McDonald and Martin­
Serrano, 2009). Both abscission and retroviral budding require 
membranes  to  be  severed  in  a  manner  that  is  topologically 
equivalent to ILV formation at MVBs, and all three processes 
are disabled by inhibiting Vps4 function (Garrus et al., 2001; 
Carlton et al., 2008). Overexpression of catalytically inactive 
Vps4 in mammalian cells dramatically increases the frequency 
of ILV budding profiles and reduces the number of freely de­
tached ILVs at MVBs (Sachse et al., 2004). However, based on 
studies of reconstituted ILV budding in vitro (Wollert et al., 
2009; Wollert and Hurley, 2010), Vps4 is thought to function 
indirectly in membrane scission by recycling ESCRT­III sub­
units for repeated rounds of assembly.
In addition to its membrane scission activity, ESCRT­III   
is required for coordinating the deubiquitination of trans­
membrane protein cargoes before their enclosure within ILVs. 
In humans, two distinct Ub hydrolases bind directly to ESCRT­III 
via microtubule­interacting and trafficking (MIT) domains   
(Agromayor and Martin­Serrano, 2006; Tsang et al., 2006; Row   
et al., 2007), and in yeast, recruitment of the Ub hydrolase Doa4 to 
ESCRT­III is promoted by Bro1, which binds both to Snf7 and 
to the Doa4 catalytic domain (Luhtala and Odorizzi, 2004; Kim 
et al., 2005; Richter et al., 2007). Bro1 and its closest human or­
thologue, Alix, each have a conserved N­terminal Bro1 domain 
that binds directly to Snf7 and CHMP4 proteins, respectively 
(Kim et al., 2005; Fisher et al., 2007). Although this interaction 
is essential for Alix to promote retrovirus budding (Fisher et al., 
2007), the means by which it contributes to ESCRT­III function 
in membrane scission remain unclear. In yeast, Bro1 likely has 
a role in ILV budding independent of its activity in regulating 
deubiquitination because ILV formation is strongly impaired by 
deletion of BRO1 but not DOA4 (Richter et al., 2007). In this 
study, we report that binding of Bro1 to Snf7 enhances the   
stability of ESCRT­III in vivo and inhibits Vps4­mediated dis­
assembly of the complex in vitro. This effect correlates with a 
reduced efficiency in detachment of ILVs from the limiting   
endosomal membrane. Conversely, mutation of the Bro1­binding 
site in Snf7 strongly inhibits vesicle formation and cargo sort­
ing. These results implicate Bro1 as a regulator of ESCRT­III 
disassembly and membrane scission activity.
Results
The Bro1 domain binds a MIM1-like motif 
in the Snf7 subunit of ESCRT-III
Yeast two­hybrid analysis (unpublished data) was used to map 
the amino acids in Snf7 required for its interaction with the 
Bro1 domain of yeast Bro1 (Fig. 1 A). This site is centered 
around residues Leu­231 and Leu­234 at the C terminus of 
Snf7, which resembles the site in CHMP4 proteins that binds 
the Bro1 domain of Alix (McCullough et al., 2008) and is simi­
lar to the MIM1 motif that was identified in Vps2/CHMP2 and 
Did2/CHMP1 proteins (Obita et al., 2007; Stuchell­Brereton   
et al., 2007). The MIT domain of Vps4 has relatively strong   
Figure 1.  The Bro1 domain binds a MIM1-like motif in Snf7. (A) Schematic 
diagrams of Bro1 and Snf7, including the amino acid sequence align-
ment of MIM1-like motifs from yeast Snf7 and human CHMP4a. (B) In vitro   
pull-downs of purified GST or GST-Bro1 domain incubated with bacterial 
lysates expressing Snf7-HA or Snf7
L231A/L234A-HA. GST and GST-Bro1   
domain inputs were loaded at 10% of their total used in each pull-down. 
IB, immunoblotting. (C) Fluorescence and DIC microscopy of vps4, vps4 
snf7, and vps4 snf7
L231/234A cells expressing GFP-Bro1 domain or GFP-
Bro1. Arrowheads indicate where GFP does (closed) or does not (open) 
colocalize with FM4-64–labeled class E compartments. Bars, 2 µm.297 Bro1 regulation of ESCRT-III • Wemmer et al.
mutant snf7
L231A/L234A that could be detected as a polymer, and 
wild­type Snf7 was similarly unaffected by overexpression of a 
mutant Bro1 domain that lacks the Snf7­binding site (Fig. S1 B), 
indicating that the effect of Bro1 domain overexpression toward 
stabilizing ESCRT­III depends on its ability to bind Snf7. Bro1 
domain overexpression caused a similar shift toward high   
density gradient fractions for another core ESCRT­III subunit, 
Vps24 (Fig. S2), although concomitant shifts in ESCRT­I or 
ESCRT­II were not observed (not depicted). However, the total 
amounts of membrane­associated Snf7 and Vps24 were not sig­
nificantly altered by overexpression of the Bro1 domain (Fig. S3), 
indicating  that  the  membrane  recruitment  step  preceding   
ESCRT­III assembly was not enhanced. Moreover, we did not 
detect an increase in the amount of Vps4 in high density gradi­
ent fractions upon overexpression of the Bro1 domain (unpub­
lished data), indicating that binding of ESCRT­III to Vps4 was 
not  dramatically  increased  under  these  conditions. Together, 
these observations suggest that driving the interaction between 
Bro1 and Snf7 by overexpression of Bro1 or the Bro1 domain 
enhances the stability of ESCRT­III assembled at endosomal 
membranes despite Vps4 being present.
Bro1 binding to Snf7 inhibits Vps4-
mediated disassembly of ESCRT-III in vitro
The stabilizing effect exerted by Bro1 toward ESCRT­III was 
examined further using an in vitro system that reconstitutes 
affinity for MIM1 of Vps2/CHMP2 and Did2/CHMP1 but binds 
poorly to the MIM1­like site in CHMP4 proteins (Kieffer et al., 
2008), which is consistent with the lack of in vitro binding   
between purified Snf7 and Vps4 (Shestakova et al., 2010; un­
published data).
Leu­231 and Leu­234 in the MIM1­like site of Snf7 were 
essential for its in vitro binding to the Bro1 domain of yeast 
Bro1 (Fig. 1 B). In vivo, these residues were also required for 
Snf7 to mediate endosomal localization of the Bro1 domain 
fused to GFP (Fig. 1 C). However, full­length Bro1­GFP weakly 
localized to endosomes despite disruption of the Bro1 domain–
binding site in Snf7 (snf7
L231A/L234A; Fig. 1 C), which matches 
our previous observation that full­length Bro1 weakly localizes 
to endosomes despite mutation of the Snf7 interaction surface 
in the Bro1 domain, whereas the same mutation completely dis­
ables endosomal localization of the Bro1 domain alone (Kim   
et al., 2005).
Bro1 binding to Snf7 enhances the 
stability of ESCRT-III polymers in vivo
The position of the Bro1 domain–binding site at the C terminus 
of Snf7 (Fig. 1) suggested that Bro1 might act like Vps20 to re­
lieve Snf7 autoinhibition (Teis et al., 2008; Saksena et al., 2009), 
thereby promoting Snf7 polymerization and incorporation into 
ESCRT­III. However, it was previously shown that Bro1 is not 
essential for Snf7 polymerization based on the analysis of cells 
in which ESCRT­III disassembly by the Vps4 ATPase had been 
disabled by deletion of the VPS4 gene (Teis et al. 2008). There­
fore, we investigated whether Bro1 might influence Snf7 poly­
merization in the context of functional Vps4 by examining the 
distribution of Snf7 in detergent­solubilized yeast membranes 
separated by isopycnic density gradient centrifugation. In ex­
tracts from wild­type cells, the majority of Snf7 was seen in low 
density fractions, but a small amount (19%) was detected in 
higher density fractions (Fig. 2, A and B). This high density pool 
of Snf7 likely corresponds to the transient ESCRT­III complexes 
that were reported to exist at steady­state (Teis et al., 2008)   
because the same gradient fractions contained 90% of Snf7 in 
extracts from vps4 cells (Fig. 2, A and B) in which ESCRT­III 
is irreversibly trapped as an assembled complex (Babst et al., 
1998; Teis et al., 2008). The polymeric Snf7 we observed had 
the same properties that were reported previously (Teis et al., 
2008)  because  its  stabilization  upon  deletion  of  VPS4  was 
largely dependent on Vps20 but not Bro1 (Fig. 2, A and B). 
Moreover, recombinant Snf7 that was expressed in bacteria and 
isolated as a soluble polymer by size­exclusion chromatography 
before being subjected to isopycnic density gradient centrifuga­
tion also migrated to high density fractions (Fig. S1 A).
Although  a  relatively  minor  percentage  of  membrane­ 
associated Snf7 was polymeric in extracts from wild­type cells 
(19%), the percentage of polymeric Snf7 increased upon over­
expression of either full­length Bro1 or the Bro1 domain (29% 
and 27%, respectively; Fig. 2, A and B). This effect required 
that Snf7 first undergo activation by Vps20 because overexpres­
sion of the Bro1 domain in vps20 cells failed to enhance   
detection of polymeric Snf7 (Fig. 2, A and B). Bro1 domain 
overexpression also did not cause an increase in the amount of 
Figure 2.  Overexpression of Bro1 or the Bro1 domain stabilizes ESCRT-III 
polymers at endosomes. (A) Western blot analysis of detergent-solubilized 
yeast membranes resolved by isopycnic density gradient centrifugation. 
Inclusion of 1% Triton X-100 throughout the gradients yielded identical 
sedimentation profiles. (B) Quantitation of triplicate gradients from A.JCB • VOLUME 192 • NUMBER 2 • 2011   298
abnormal  endosomal  structures  known  as  class  E  compart­
ments, which consist of stacks of aberrantly flattened endo­
somes that generally lack ILVs (Fig. 4 B and Video 2), which is 
consistent  with  ESCRT­III  promoting  membrane  scission.   
Expression of the snf7
L231A/L234A allele in place of wild­type 
SNF7 did not result in class E compartments like those seen in 
snf7 cells. Nevertheless, this mutation caused a sharp reduc­
tion in the number of ILVs and a gross distortion of endosomes 
in a manner reminiscent of the class E compartment morphol­
ogy (Fig. 4 C, Fig. 5 C [quantification], and Video 3). This reduc­
tion in the amount of ILVs is consistent with the interpretation 
that Bro1 binding to Snf7 is critical for proper ESCRT­III func­
tion in vivo.
Unexpectedly,  we  discovered  that  Bro1  domain  over­
expression in wild­type cells increased the frequency of intra­
lumenal invaginations that had not detached from the limiting 
endosomal membrane (Fig. 4, D and E; and Videos 4 and 5). 
Such ILV budding profiles are not common, with a mean of 1.2 
observed per MVB in wild­type cells, but 2.4 budding profiles 
per MVB on average were seen upon overexpression of the 
Bro1  domain  (Fig.  5 A).  Plotting  the  frequency  distribution   
of ILV budding profiles (Fig. 5 B) showed that overexpression 
of the Bro1 domain resulted in more instances of multiple 
budding profiles at individual MVBs (five budding profiles at 
the MVB shown in Fig. 4 E; Video 5). Overexpression of full­
length Bro1 had the same effect as the Bro1 domain (Fig. 4 F; 
Fig. 5, A and B; and Video 6), demonstrating that the increase in 
ILV budding profiles was not simply caused by the absence of 
an activity normally provided by the C­terminal region of Bro1. 
A gallery of tomograms highlighting ILV budding profiles   
versus detached ILVs at individual MVBs in wild­type cells 
with and without overexpression of Bro1 or the Bro1 domain is 
shown in Fig. 4 (G–L).
The low frequency of ILV budding profiles in wild­type 
yeast presumably reflects the rapid rate at which membrane 
scission normally occurs. This process is most likely delayed 
rather than accelerated in response to Bro1 or Bro1 domain 
overexpression because quantitation of membrane surface areas 
showed a decrease in the lumenal membrane content and a cor­
responding increase in the amount of limiting membrane (Fig. 5 C),   
although the mean vesicle diameter did not change (Fig. 5 D). 
In contrast, an acceleration of ILV formation would be expected 
to show an increase in the amount of lumenal membrane con­
tent within endosomes, as is observed in yeast lacking Ist1 
(Nickerson et al., 2010), an accessory ESCRT­III protein that 
inhibits Vps4 activity (Dimaano et al., 2008). Compared with 
wild­type cells, the ratio of lumenal to limiting membrane sur­
face area was lower upon mutation of the Bro1 domain–binding 
site in Snf7 (snf7
L231A/L234A; 23.3% of total endosomal membrane 
surface area was lumenal; Fig. 5 C), whereas snf7 cells were 
almost exclusively devoid of lumenal membranes (0.27% of the 
total endosomal membrane surface area; Fig. 5 C), which is 
consistent with the stronger effects on endosomal morphology 
caused by these mutations (Fig. 4).
Measurements of tomograms further revealed that the 
amount of membrane incorporated into ILV budding profiles 
in wild­type cells accounted for only 6.3% of the limiting 
Vps4­mediated disassembly of the complex. In this assay,   
membrane­associated ESCRT­III generated from extracts of vps4 
cells were incubated with 1 mM ATP and 10 nM purified Vps4 
for 10 min at 30°C, and the extent of ESCRT­III disassembly 
was determined by probing the amount of Snf7 that remains 
membrane associated after centrifugation. As shown previously 
(Davies et al., 2010), this reaction condition resulted in a 50% 
reduction in membrane­associated Snf7 (Fig. 3 A), indicating 
that exogenous Vps4 has potent activity in mediating in vitro 
disassembly of ESCRT­III that had been preassembled in vivo. 
However, this activity was inhibited by 50% if ESCRT­III was 
generated from vps4 cells overexpressing the Bro1 domain and, 
to a lesser degree, if the source of ESCRT­III was vps4 cells over­
expressing full­length Bro1 (Fig. 3 A).
The inhibitory effect of Bro1 on in vitro disassembly of 
ESCRT­III (Fig. 3 A) was similar to the in vivo results seen in 
Fig. 2, wherein the stability of membrane­associated ESCRT­III 
was enhanced upon overexpression of Bro1 or the Bro1 domain. 
Although these observations support a model in which Bro1 
binding to Snf7 interferes with Vps4­mediated disassembly of 
ESCRT­III, an alternative possibility was that excess Bro1 or 
Bro1 domain compromises the ESCRT­III assembly process 
and results in aberrant complexes refractory to Vps4. However, 
the addition of purified Bro1 domain (fused to GST) effectively 
negated in vitro Vps4­mediated disassembly of preassembled 
ESCRT­III generated from vps4 cells (Fig. 3 B). Moreover, 
this inhibitory effect was observed even if Vps4 was allowed to 
initiate disassembly of ESCRT­III for 5 min before the addition 
of GST­Bro1 domain (Fig. 3 C). Thus, Bro1 inhibition of Vps4­
mediated disassembly of ESCRT­III is manifested downstream 
of complex assembly.
We also tested whether the inhibitory effect of the Bro1 
domain relied exclusively on its ability to bind Snf7 by generat­
ing ESCRT­III from vps4 cells in which a Snf7
Vps2MIM1 chi­
mera was expressed in place of wild­type Snf7. In this chimera, 
the MIM1­like Bro1 domain–binding site is replaced with the 
bona fide MIM1 from Vps2 that binds the MIT domain of Vps4 
(Obita et al., 2007). The Snf7
Vps2MIM1 chimera rescues in vitro 
Vps4­mediated disassembly of ESCRT­III formed in the ab­
sence of Vps2 expression, demonstrating that it effectively 
serves as a substrate for Vps4 (Davies et al., 2010). Similarly, 
ESCRT­III assembled with Snf7
Vps2MIM1 in place of wild­type 
Snf7 was susceptible to disassembly by Vps4 even upon addi­
tion of purified Bro1 domain (Fig. 3 D). We conclude that direct 
binding of the Bro1 domain to Snf7 inhibits Vps4­mediated dis­
assembly of ESCRT­III.
Overexpression of Bro1 or the Bro1 
domain reduces ILV budding efficiency  
at MVBs
To  evaluate  whether  binding  of  the  Bro1  domain  to  Snf7   
influences the membrane scission activity of ESCRT­III, we   
examined the morphology of yeast endosomes by EM and 3D 
tomography. Deletion of SNF7 or genes encoding the other core 
ESCRT­III subunits inhibits the biogenesis of MVBs like those 
seen in wild­type cells (Fig. 4 A and Video 1). Instead, snf7 
cells (and other ESCRT­III deletion strains; not depicted) have 299 Bro1 regulation of ESCRT-III • Wemmer et al.
endosomal membrane surface area. In contrast, overexpression 
of Bro1 or the Bro1 domain resulted in the incorporation of 
18.6% and 17.5%, respectively (Fig. 5 E), which is propor­
tional  to  the  increased  frequency  of  ILV  budding  profiles   
observed under these conditions (Fig. 5 A). Despite the increase 
in the number of ILV budding profiles, their overall morphol­
ogy was not altered significantly, as neither the diameter of 
the  vesicles  attached  to  the  limiting  endosomal  membrane 
Figure 3.  Bro1 binding to Snf7 inhibits in vitro disassembly of ESCRT-III. (A) 0.1 µM purified Vps4, ATP, and an ATP regeneration system were incubated 
with membranes isolated from vps4 yeast cells; overexpression of full-length Bro1 or the Bro1 domain (BOD) is indicated. The amount of membrane- 
associated Snf7 remaining after incubation at 30°C for 10 min was determined by quantitative Western blot analysis. P < 0.001 for both samples.   
(B) In vitro ESCRT-III release performed in the presence or absence of ATP, 0.1 µM Vps4, and 0.1 µM GST-Bro1 domain (GST-BOD). (C) In vitro ESCRT-III 
release performed as in B except that the reaction was allowed to proceed for 5 min in the absence of GST-BOD or for 20 min in the absence or presence 
of 1 µM GST-BOD that was added either at the same time as purified Vps4 or 5 min after the addition of Vps4. (D) In vitro ESCRT-III release performed 
with membranes from yeast expressing wild-type Snf7 or the Snf7
Vps2MIM1 chimera in the presence or absence of ATP, 0.1 µM Vps4, and 0.1 µM GST-BOD. 
Error bars show the standard deviation.JCB • VOLUME 192 • NUMBER 2 • 2011   300
Figure 4.  Endosome morphologies in cells overexpressing Bro1 or the Bro1 domain. (A–F) 2D cross sections and 3D models from 200-nm-thick section 
electron tomograms. Spherical endosomal limiting membranes are depicted in yellow, whereas flattened class E compartments are depicted in various 
colors to discriminate discrete membranes. Lumenal vesicles are red. V, vacuole. Bars, 100 nm or 200 nm as noted. (G–L) Gallery of tomographic slices 
of wild-type cells with and without overexpression of Bro1 or the Bro1 domain. Freely detached ILVs are traced in red, whereas ILV budding profiles and 
the limiting endosomal membrane are traced in yellow. In some cases, the continuity of ILV budding profiles with the limiting endosomal membrane is out 
of plane in the tomographic slice but evident in the 3D reconstruction. Bars, 50 nm.301 Bro1 regulation of ESCRT-III • Wemmer et al.
(Fig. S4 A) nor the diameter of the membrane neck at ILV 
budding  profiles  (Fig.  S4  B)  were  statistically  different  in 
wild­type cells with or without overexpression of Bro1 or the 
Bro1 domain.
Cargo sorting and deubiquitination are 
not affected by Bro1 or Bro1 domain 
overexpression in wild-type cells
Transmembrane proteins sorted into the ILVs of MVBs are   
ultimately delivered to the vacuole lumen upon MVB–vacuole   
fusion, but disrupting the activity of any of the ESCRTs results 
in mislocalization of these cargoes to the vacuole membrane 
and their accumulation at class E compartments (Odorizzi   
et  al.,  1998). Therefore,  we  evaluated  how  the  effects  on   
ILV budding revealed by EM tomography (Fig. 4) impacted 
the efficiency of cargo sorting using live cell fluorescence 
microscopy of yeast expressing GFP fused to the cytoplasmic 
domain of carboxypeptidase S (GFP­CPS). We previously 
reported mislocalization of GFP­CPS upon mutation of the 
Snf7­binding site in the Bro1 domain (Kim et al., 2005). Simi­
larly, mislocalization of GFP­CPS occurred both in snf7 cells 
and in snf7
L231A/L234A cells lacking the Bro1­binding site within 
Snf7 (Fig. 6 A), which was consistent with the strong reduc­
tion in ILV formation caused by these mutations (Fig. 5). Deliv­
ery of GFP­CPS into the vacuole lumen in wild­type cells was 
only mildly affected upon overexpression of the Bro1 domain 
(Fig. 6 A), whereas full­length Bro1 overexpression did not 
appear to cause significant cargo mislocalization (Luhtala and 
Odorizzi, 2004).
Doa4 is the Ub hydrolase that deubiquitinates CPS and 
other  MVB  vesicle  cargoes  (Dupré  and  Haguenauer­Tsapis, 
2001; Katzmann et al., 2001; Losko et al., 2001), and its activity 
is stimulated upon binding to Bro1 (Richter et al., 2007). 
This process occurs efficiently in wild­type cells, resulting in 
detection of very little ubiquitinated CPS (Ub­CPS; Fig. 6 B). 
In contrast, Ub­CPS accumulated upon deletion of SNF7 or 
upon mutation of its Bro1 domain–binding site (snf7
L231A/L234A; 
Fig. 6 B), demonstrating that its interaction with Snf7 is im­
portant for Bro1 to promote Doa4 activity at endosomes. Con­
versely, overexpression of Bro1 or the Bro1 domain had no 
observable effects on CPS deubiquitination (Fig. 6 B), indicat­
ing that the enhancement of ESCRT­III stability and reduced   
efficiency in membrane scission is not a consequence of altered 
Doa4 function.
Figure  5.  Quantitation of endosome morphology and vesicle budding 
profiles. Quantitation of the mean number of ILV budding profiles observed 
per MVB (A) versus the frequency distribution of the number of ILV budding 
profiles observed per MVB (B) observed in tomograms. Quantitation of the 
relative percentage of limiting versus lumenal membrane surface areas (C) 
and the mean ILV diameters (D) observed in tomograms. (E) The percent-
age of the limiting membrane incorporated into ILV budding profiles was 
measured for each strain. Note that no ILV budding profiles were seen for 
snf7 cells, but five freely detached ILVs were observed at the periphery 
of a class E compartment in a single tomogram of snf7 cells (Fig. S5); the 
rarity of this occurrence is reflected by the observation that the membrane 
surface area of these ILVs comprised 0.27% of the total endosomal mem-
brane surface area in this strain. Tomograms for 12, 14, and 17 MVBs 
were prepared and modeled for wild-type cells, cells overexpressing the 
Bro1 domain, and cells overexpressing full-length Bro1, respectively. Four 
individual tomograms were prepared and modeled for snf7
L231A/L234A cells, 
which contained a total of 33 MVB, VTE, and cisternal structures. Three 
individual tomograms were generated and modeled for snf7 cells, each 
containing E compartments that were composed of multiple cisternal stacks 
and occasionally also spherical endosomal membranes. Methods used for 
the preparation of the tomograms that were used to generate the measure-
ments shown in this experiment are described in detail in the Materials and 
methods section.
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S. cerevisiae has been elusive because of the formation of aber­
rant class E compartments rather than MVBs in mutant yeast 
that generally lack functional ESCRT complexes (Rieder et al., 
1996;  Odorizzi  et  al.,  1998;  Luhtala  and  Odorizzi,  2004; 
Nickerson et al., 2006). In this study, we describe a potential 
role for Bro1 in regulating ESCRT­III by demonstrating that 
overexpression of either full­length Bro1 or its N­terminal Bro1 
domain stabilizes ESCRT­III polymers and reduces the efficiency 
of ILV detachment from the limiting endosomal membrane in 
yeast that contain an otherwise wild­type ESCRT machinery.
ILV budding profiles in yeast are infrequently observed, 
even in thick sections imaged by 3D EM tomography, presum­
ably because of the rapid rate at which membrane deformation 
and scission occur. The increased frequency of budding profiles 
caused by overexpression of Bro1 or the Bro1 domain must be 
interpreted as a reduction in ILV budding efficiency rather than 
an acceleration because these conditions also resulted in signifi­
cantly less lumenal membrane content within MVBs. In the ab­
sence of monitoring this process in real time, it is impossible to 
exclude whether at least some of the ILV budding profiles are 
dead­end structures that fail to complete membrane scission. 
However, the ILVs seen in cells overexpressing Bro1 or the 
Bro1 domain appeared structurally normal. Neither their overall 
mean diameter nor the dimensions at the necks of the budding 
profiles were significantly different from the same measure­
ments in wild­type cells, suggesting that these ILVs will eventu­
ally detach from the limiting endosomal membrane.
The specific mechanism underlying the reduced efficiency 
of ILV budding resulting from overexpression of Bro1 or the Bro1 
domain is unclear, but a clue comes from our finding that this con­
dition correlates with increased detection of Snf7 and Vps24, both 
core ESCRT­III subunits, in a high molecular mass polymer de­
spite wild­type Vps4 expression. Vps4 is the AAA­ATPase that 
catalyzes disassembly of ESCRT­III (Babst et al., 1998), which 
accounts  for  very  little  of  the  assembled  complex  existing  at 
steady­state (Teis et al., 2008). Based on in vitro reconstitution of 
ILV budding, Vps4 is thought to function indirectly in membrane 
scission by recycling ESCRT­III subunits for repeated rounds of 
assembly (Wollert et al., 2009; Wollert and Hurley, 2010). Given 
the intermediate degree to which Snf7 polymers are stabilized 
upon Bro1 or Bro1 domain overexpression (only 30% of the   
total amount of Snf7 that is trapped as a polymer in vps4 cells),   
it seems unlikely that a deficiency of free ESCRT­III subunits exists 
for complex assembly and subsequent execution of membrane 
scission. However, we presently cannot determine whether Bro1­
mediated stabilization of ESCRT­III is the direct cause of the re­
duced efficiency in ILV budding, which would suggest an active 
role for Vps4 during membrane scission in vivo. Nevertheless, the 
possibility that membrane scission might be coupled to Vps4 ac­
tivity is consistent with our previous discovery by EM tomogra­
phy that MVBs have significantly more ILVs in the absence of 
Ist1 (Nickerson et al., 2010), an accessory ESCRT­III protein that 
negatively regulates Vps4 by inhibiting its binding to ESCRT­III 
(Dimaano et al., 2008). An active role for Vps4 in membrane scis­
sion might also explain why overexpression of catalytically in­
active Vps4 in mammalian cells results in an increased frequency 
of ILV budding profiles at endosomes (Sachse et al., 2004).
Discussion
In  vitro  studies  have  pointed  to  the  assembly  of  ESCRT­III   
being crucial to the membrane scission event that results in de­
tachment of ILVs (Wollert et al., 2009; Wollert and Hurley, 
2010). Although the specific mechanism by which ESCRT­III 
executes this activity is unclear, its role in severing membrane 
connections is supported by in vivo studies of mammalian cells, 
showing  a  requirement  for  ESCRT­III  in  cytokinesis  and   
retroviral budding, both of which are membrane scission events 
that are topologically equivalent to ILV formation at MVBs   
(McDonald and Martin­Serrano, 2009). Genetic dissection of 
the  mechanism  of  action  for  ESCRT­III  at  endosomes  in   
Figure 6.  Cargo sorting and deubiquitination. (A) Fluorescence and DIC 
microscopy of cells expressing GFP-CPS. Bars, 2 µm. (B) Western blot   
analysis of anti-CPS immunoprecipitates. IB, immunoblotting.303 Bro1 regulation of ESCRT-III • Wemmer et al.
because complete removal of Bro1 function by deletion of the 
BRO1 gene results in class E compartments rather than MVBs 
(Luhtala and Odorizzi, 2004; Richter et al., 2007). Bro1 stimu­
lates transmembrane protein cargo deubiquitination at endo­
somes by promoting both recruitment and activation of the 
Doa4 Ub hydrolase (Luhtala and Odorizzi, 2004; Richter et al., 
2007). However, this activity alone cannot account for the im­
portance of the Bro1–Snf7 interaction during membrane scis­
sion because mutations that specifically disable Bro1 from 
stimulating Doa4 do not impair ILV formation, nor does re­
placement of wild­type DOA4 with nonfunctional alleles (Richter 
et al., 2007).
The strong reduction in ILV formation seen in snf7
L231A/L234A 
cells is consistent with the failure in delivery of CPS to the   
vacuole lumen via the MVB pathway. Given the central role 
Bro1 has in regulating deubiquitination at endosomes, it is not 
surprising that disruption of the Bro1 domain–binding site in 
Snf7 caused a strong accumulation of Ub­CPS. However, the 
efficiency of cargo deubiquitination controlled by endogenous 
full­length Bro1 in wild­type cells suffered virtually no reduc­
tion upon overexpression of the Bro1 domain. The C terminus 
of Bro1 stimulates Doa4 Ub hydrolase activity (Richter et al., 
2007), and this region is absent from the Bro1 domain (Fig. 1 A), 
which would compete with endogenous Bro1 for binding to 
Snf7. Although its interaction with Snf7 comprises the primary 
mechanism for endosomal recruitment of Bro1, a small amount 
of Bro1 is detectable at endosomes if this interaction has been 
disabled (Fig. 1 C; Kim et al., 2005). The fact that cargo deubiq­
uitination is not significantly compromised by Bro1 domain 
overexpression suggests that the Snf7­independent mechanism 
of Bro1 recruitment to endosomes (which has yet to be defined) 
might be sufficient to maintain Doa4 function.
The inhibition of ESCRT­III disassembly resulting from 
Bro1 binding to Snf7 might be critical for ESCRT­III reaching 
a state of assembly necessary to execute membrane scission, 
explaining the strong reduction in the efficiency of ILV forma­
tion observed upon disruption of the Bro1­binding site in Snf7. 
A similar stabilizing role for Alix would be consistent with ob­
servations that disruption of its interaction with CHMP4 pro­
teins impairs cytokinesis and reduces the efficiency of retrovirus 
budding (Carlton and Martin­Serrano, 2007; Fisher et al., 2007; 
Morita et al., 2007; Usami et al., 2007; Carlton et al., 2008). At   
endosomes, a regulatory function in promoting ESCRT­III assem­
bly would place Bro1 at the appropriate time and place to coordi­
nate deubiquitination of transmembrane protein cargoes with the 
detachment of ILVs. However, a mechanism for coupling these 
seemingly separate activities of Bro1 has yet to be discovered.
Materials and methods
Yeast strains and plasmid constructions
Standard protocols were used to construct all yeast strains and plasmids 
described in Tables I and II (Longtine et al., 1998). The bacterial expres-
sion plasmid encoding SNF7-HA (pGO619) was constructed in vector 
pST39 (Tan, 2001) using a PCR product created from the wild-type SNF7 
coding sequence and a reverse primer that includes one copy of the HA 
epitope. The L231A/L234A point mutations were created by site-directed 
mutagenesis of pGO619, yielding pGO621. The 2-µm plasmid encoding 
the Bro1 domain (pMWM3) was constructed by homologous recombination 
The membrane scission activity of ESCRT­III in vitro is 
potently stimulated by ESCRT­II (Im et al., 2009), which is 
thought to trigger ESCRT­III polymerization through its direct 
binding to Vps20 (Saksena et al., 2009). Unlike ESCRT­III, 
however, ESCRT­II is not required for the budding of human 
immunodeficiency virus­1 (HIV­1; Langelier et al., 2006), rais­
ing the question of how ESCRT­III assembly is stimulated at the 
site of viral budding. The p6 domain of the Gag polyprotein of 
HIV­1 binds both to Alix (Strack et al., 2003) and to TSG101, a 
subunit of ESCRT­I (Garrus et al., 2001; Martin­Serrano et al., 
2001; VerPlank et al., 2001). The yeast orthologue of TSG101 
(Vps23) also binds Vps20 (Bowers et al., 2004; Teo et al., 2004), 
but an interaction between TSG101 and ESCRT­III has not been 
reported. Binding of Alix alone to p6 is sufficient to promote 
HIV­1 budding (Fisher et al., 2007; Usami et al., 2007), but 
whether this interaction facilitates ESCRT­III assembly is un­
known. Our results suggest that Bro1 in yeast lacks this activity 
because its ability to stabilize ESCRT­III when overexpressed 
was dependent on the presence of Vps20.
Bro1 exerts its stabilization effect toward ESCRT­III 
downstream of complex assembly because the addition of   
exogenous Bro1 domain to preassembled ESCRT­III was suf­
ficient to protect the complex from Vps4­mediated disassembly   
in vitro. Direct binding to Snf7 was required for Bro1 to inhibit 
ESCRT­III disassembly both in vivo and in vitro. The site at   
the C terminus of Snf7 to which the Bro1 domain binds is con­
served, as a similar motif was identified at the C terminus of   
human CHMP4 proteins and shown to be required for binding 
to the Bro1 domain of Alix (McCullough et al., 2008). The amino 
acid sequence of this motif and its position near the C terminus 
of Snf7 resemble the MIM1 sites in Vps2/CHMP2 and Did2/
CHMP1 that bind directly to the MIT domain of Vps4, but this 
site in Snf7 and CHMP4 proteins lacks residues critical for the 
MIT interaction (Obita et al., 2007; Stuchell­Brereton et al., 
2007). Thus, it is unlikely that Bro1 stabilizes ESCRT­III by di­
rectly masking a site at which Vps4 might bind Snf7. Located 
upstream of the MIM1­like site in Snf7 and CHMP4 proteins is 
a second motif (MIM2) that binds weakly to the Vps4 MIT do­
main in vitro (Kieffer et al., 2008). Although it is possible that 
the Bro1 domain interaction sterically shields Vps4 recognition 
of the MIM2 site in Snf7, testing this hypothesis has been prob­
lematic because the Snf7–Vps4 interaction is so weak that we 
cannot detect binding of either full­length Snf7 or a fragment 
encompassing MIM2 either to full­length Vps4 or to the Vps4 
MIT domain in isolation (unpublished data).
Snf7 is the predominant subunit of the ESCRT­III poly­
mer (Teis et al., 2008) and is critical for the membrane scission 
activity of the complex in vitro (Wollert et al., 2009). EM tomog­
raphy suggests the membrane scission activity of ESCRT­III   
at endosomes in yeast relies on Snf7 binding to the Bro1 do­
main because snf7
L231A/L234A cells, which have otherwise wild­
type ESCRT protein activity, exhibit a strong reduction in the 
number of ILVs and a concomitant expansion of the limiting 
endosomal membrane, a morphology reminiscent of class E com­
partments seen in snf7 cells and other ESCRT mutant strains. 
The residual localization of full­length Bro1 to endosomes in 
snf7
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at 300 kv was used for dual-tilt series images collected from 60 to 60° 
with 1° increments. Tilt series were shot at 31,000× magnification with a 
0.764-nm working pixel (binning 2) and repeated at a 90° rotation for dual-
axis tomography. 15-nm fiducial gold was used to coat sections on both 
sides for reconstruction of back projections using IMOD software. Manually 
assigned contours of the endosomal limiting membrane at the inner leaflet 
were used to measure the surface of the bilayers periodically every 3.85 nm 
and calculated using imodmesh. Best-fit sphere models were used to mea-
sure the diameters of nearly spherical lumenal vesicles from the outer leaflet 
of the membrane bilayers. Videos 1–6 were made from IMOD images and 
completed in QuickTime. Quantitation of ILV budding profiles/MVB were 
normalized to the mean percent MVB accounted for in the tomograms to 
more accurately represent the number of ILV budding profiles per MVB.
Isopycnic density gradient centrifugation
For the resolution of native ESCRT complexes, 20 A600 equivalents of cells 
were converted to spheroplasts, resuspended in 1 ml ice-cold lysis buffer 
(200 mM sorbitol, 50 mM potassium acetate, 20 mM Hepes, pH 7.2, and 
2 mM EDTA) supplemented with protease inhibitors, and homogenized on 
ice. Soluble and membrane fractions were separated by spinning the ly-
sates at 13,000 g for 15 min at 4°C. The resulting membrane pellet was 
resuspended in 950 µl lysis buffer, then solubilized by the addition of 0.5% 
Triton X-100 and rotation at 4°C for 30 min. Solubilized membranes were 
loaded onto the top of a 10–70% sucrose gradient prepared with the Tris 
gradient system (Biocomp Instruments) using 10% and 70% sucrose stocks 
prepared in 200 mM sorbitol, 50 mM potassium acetate, 20 mM Hepes, 
pH 7.2, and 2 mM EDTA. The gradient was subjected to centrifugation in 
an SW41 rotor (Beckman Coulter) at 100,000 g for 16–20 h at 4°C, and 
fractions were collected from the top. Sodium deoxycholate (0.015% final) 
and trichloroacetic acid (10% final) were added to each fraction, and pro-
teins were precipitated on ice for at least 30 min, followed by centrifuga-
tion at 13,000 g for 10 min. Insoluble material was reprecipitated twice 
by sonication into ice-cold acetone and centrifugation, then sonicated into 
Laemmli sample buffer and resolved by SDS-PAGE, transferred to nitro-
cellulose, and examined by Western blotting using antisera against Snf7, 
Vps24, or GFP (Roche). Quantitation was performed on triplicate experi-
ments by incubating membranes with Alexa Fluor 680 secondary antibody 
(Invitrogen) and visualizing with an infrared imager (Odyssey; LI-COR Bio-
sciences). Bands were quantitated with Odyssey software (version 2.1). 
For the snf7
L231A/L234A strain, 40 A600 equivalents were used because of de-
creased detection of the mutant version of the protein. The presence of 1% 
Triton X-100 throughout the sucrose gradient yielded identical results to 
gradients performed where Triton X-100 was omitted from the gradient.
of linearized pRS426 with a PCR product containing the Bro1 promoter 
and Bro1 codons 1–387.
Protein interaction experiments
Lysates  of  bacteria  expressing  Snf7-HA  or  Snf7
L231A/L234A-HA  were  pre-
pared from cultures of BL21 (DE3; Agilent Technologies) transformed with 
pGO619 or pGO621; protein expression was induced at 20°C for 20 h 
after the addition of 0.5 mM isopropyl--d-thiogalactoside. Purified GST-
Bro1 domain was obtained on glutathione Sepharose resin (GE Health-
care) from lysates of BL21 (DE3) that had been transformed with a plasmid 
encoding this gene fusion (Kim et al., 2005) and induced to express re-
combinant protein. For in vitro pull-down experiments, glutathione Sepha-
rose and 5 µg GST-Bro1 domain (or GST alone) were incubated for 1 h at 4°C 
with lysates prepared from bacteria expressing Snf7-HA or Snf7
L231/L234A-HA. 
Bound proteins were recovered by centrifugation of the resin, which was 
washed thrice with ice-cold PBS + 0.5% Triton X-100, then washed twice 
with ice-cold PBS. Bound proteins were eluted from the resin by boiling   
in  Laemmli  sample  buffer,  resolved  by  SDS-PAGE,  and  transferred  to   
nitrocellulose for Western blot analysis using anti-HA monoclonal antiserum 
(Roche). 10% of the amount of GST or GST-Bro1 used in each pull-down 
was resolved by SDS-PAGE and analyzed by Coomassie staining.
Microscopy
Fluorescence microscopy of cells labeled with N-[3-triethylammonium-
pro-pyl]-4-[p-diethylaminophenylhexatrienyl] pyridinium dibromide (FM4-64) 
and/or expressing GFP was performed as described previously (Luhtala 
and Odorizzi, 2004) using a microscope (Axioplan 2; Carl Zeiss, Inc.) 
equipped with an NA 1.40 oil immersion 100× objective (Carl Zeiss, Inc.) 
at room temperature in minimal media. Differential interference contrast 
(DIC) and fluorescence microscopy images were acquired with a digital 
camera (Cooke Sensicam; Applied Scientific Instruments, Inc.) and pro-
cessed using Slidebook (Intelligent Imaging Innovations) and Photoshop 
software (version CS2; Adobe).
For EM, yeast cells were high pressure frozen and freeze substituted 
as previously described (Nickerson et al., 2006; Richter et al., 2007) and 
embedded at 60°C in Lowicryl HM20 (Polysciences). Plastic blocks were 
trimmed and cut in 80-nm-thin sections and 250-nm-thick sections with a 
microtome (Leica) and placed on rhodium-plated copper slot grids. Tomo-
graphic  samples  were  stained  en  bloc  with  0.1%  uranyl  acetate  and 
0.25% glutaraldehyde as a minimal fixative with no additional after stain-
ing except for snf7, which required 0.1% uranyl acetate and 2% glutar-
aldehyde for sufficient preservation for tomography. Thick sections were 
mapped on a transmission EM (Phillips CM10) at 80 kv, then a Tecnai 30 (FEI) 
Table I.  S. cerevisiae strains used in this study
Name Genotype Reference
SEY6210 Mata leu2-3,112 ura3-52 his3200 trp1-901 lys2-801 suc2-9 Robinson et al.,1988
MBY3 SEY6210; vps4::TRP1 Babst et al., 1997
TVY1 SEY6210; pep4::LEU2 Gerhardt et al., 1998
MWY22 SEY6210; pep4::LEU2 snf7::HIS3 This study
MWY24 SEY6210; snf7::HIS3 This study
MWY25 SEY6210; snf7L231A/L234A::KAN This study
MWY26 SEY6210; snf7L231A/L234A-KAN vps4::TRP1 This study
CRY181 SEY6210; snf7L231A/L234A-KAN vps4::TRP1 pep4::LEU2 This study
EEY12 SEY6210; snf7::HIS3 vps4::TRP1 Babst et al., 2002
MBY41 SEY6210; vps20::HIS3 vps4::TRP1 Babst et al., 2002
GOY66 SEY6210; bro1::HIS3 vps4::TRP1 Odorizzi et al., 2003
GOY65 SEY6210; bro1::HIS3 Odorizzi et al., 2003
EEY2-1 SEY6210; vps20::HIS3 Babst et al., 2002
MBY52 SEY6210; vps4::TRP1 pep4::LEU2 prb1::LEU2 Katzmann et al., 2003
JPY140 SEY6210; vps4::TRP1 pep4::LEU2 snf7::HIS3 Davies et al., 2010
CRY39 SEY6210; Vps23-GFP::KAN Nickerson et al., 2010
CRY40 SEY6210; Vps23-GFP::KAN vps4::TRP1 Nickerson et al., 2010
GOY150 SEY6210; Vps36-GFP::HIS3 Nickerson et al., 2010
GOY151 SEY6210; Vps36-GFP::HIS3 vps4::TRP1 Nickerson et al., 2010
GOY74 SEY6210; Doa4-GFP::HIS3 Luhtala and Odorizzi, 2004
GOY75 SEY6210; Doa4-GFP::HIS3 vps4::TRP1 Luhtala and Odorizzi, 2004305 Bro1 regulation of ESCRT-III • Wemmer et al.
seen within the tubular endosome. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201007018/DC1.
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In vitro ESCRT-III release assay
The in vitro ESCRT-III release assay was performed as previously described 
(Davies et al., 2010). Purified Vps4 and an ATP regeneration system (10 mM 
phosphocreatine, 10 U/ml creatine phosphokinase, and 1 mM ATP) were 
added to yeast membrane fractions containing ESCRT-III complexes (Babst 
et al.,1997; Azmi et al., 2006). Membranes were generated from shero-
plasted cells that were lysed under native conditions and homogenized, 
then resuspended in ATPase reaction buffer (100 mM KOAc, 20 mM Hepes, 
pH 7.4, and 5 mM MgOAc) and passed through an 18-G needle three 
times followed by a 30-G needle five times to homogenize the membranes. 
Reactions were allowed to incubate for 10 min at 30°C, then subjected to 
centrifugation at 13,000 g to separate the membrane-associated and solu-
ble ESCRT-III. SDS-PAGE followed by Western blot analyses was performed 
with anti-Snf7 antiserum and quantitated using ImageQuant software.
Ub-CPS immunoprecipitation
Detection of Ub-CPS was performed as described previously (Katzmann   
et al., 2001). The vacuolar protease gene PEP4 was deleted in all strains 
to reduce the nonspecific cleavage of Ub from CPS after cellular lysis.   
10 A600 equivalents of cells were harvested and precipitated by the addition 
of trichloroacetic acid (10% final concentration). Whole cell lysates were 
generated by glass bead disruption in urea buffer (6 M urea, 1% SDS,   
50 mM, Tris pH 7.5, 1 mM EDTA, and 5 mM NEM), spun at 13,000 g to 
clear, the supernatant was transferred to a new tube, and CPS was immuno-
precipitated with anti-CPS polyclonal antiserum and protein A–Sepharose. 
Immunoprecipitates  were  spun  down  and  washed  four  times,  and  the 
beads dried. Samples were resuspended in sample buffer, and 0.5 OD600 
equivalents  were  subjected  to  SDS-PAGE,  transferred  to  nitrocellulose, 
which was autoclaved twice, blocked in 20% fetal calf serum, and probed 
with antibodies against Ub (Invitrogen) or CPS.
Online supplemental material
Fig. S1 shows that Bro1 binding to Snf7 is required for the stabilization of 
ESCRT-III polymers at endosomes. Fig. S2 shows that overexpression of the 
Bro1 domain stabilizes ESCRT-III subunit Vps24 at the endosomal mem-
brane. Fig. S3 reveals that the subcellular distribution of ESCRT-III proteins 
is not altered by overexpression of full-length Bro1 or the Bro1 domain. Fig. S4 
demonstrates that the diameters of the membrane necks and vesicles con-
tained within ILV budding profiles do not significantly between wild-type 
cells and cells overexpressing Bro1 or the Bro1 domain. Fig. S5 shows a 
tomographic model of an snf7 class E compartment that contains five   
intralumenal vesicles. Video 1 shows a 3D reconstruction of MVBs from a 
wild-type cell, the top MVB contains a vesicle budding profile. Video 2 
contains a 3D reconstruction of an snf7 class E compartment. Video 3 
shows endosomal structures from snf7
L231A/L234A cells in which the endo-
somes appear to be intermediates between wild-type MVBs and E com-
partments. Video 4 highlights an MVB from cells overexpressing the Bro1 
domain. The MVB contains a single ILV budding profile and several intra-
lumenal vesicles. Video 5 contains a tomographic model of an MVB from 
cells overexpressing the Bro1 domain in which five simultaneous ILV bud-
ding profiles can be observed. Video 6 shows a cluster of three endosomes 
from cells overexpressing full-length Bro1. Two ILV budding profiles can be 
Table II.  Plasmids used in this study
Plasmid Protein expressed Description
pGO337 GFP-Bro1 1-387 GFP-Bro1
1-387 URA3 Ap
R (pRS416)
pGO339 GFP-Bro16 GFP-Bro1 URA3 Ap
R (pRS41)
pGO47 GFP-CPS Odorizzi et al., 1998
pCR180 GFP-Sna3 URA3 Ap
R (pRS415) GFP-Sna3
pGO547 Snf7 pST39 Shine-Delgarno Snf7
pGO619 Snf7-HA pST39 Shine-Delgarno Snf7-HA
pGO621 Snf7
L231A/L234A-HA pST39 Shine-Delgarno Snf7 L231A/L234A-HA
pGEX-4T1 GST GE Healthcare
pGO626 GST-Bro1
1-387-HA pGEX-4T1 GST-Bro1 1-387-HA
pMB54 GST-Vps4 Azmi et al., 2006
pGO216 Bro1 URA3 ApR (pRS426) Bro1
pMWM3 Bro11-387 URA3 ApR (pRS426) Bro11-387
pRS426 Snf7 Snf7 Davies et al., 2010
pRS426 Snf7Vps2MIM1 Snf7Vps2MIM1 Davies et al., 2010JCB • VOLUME 192 • NUMBER 2 • 2011   306
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